Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

Boehringer Ingelheim · Phase 2 · Completed · Enrollment 387

NCT04667377

EudraCT 2020-002479-37

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

60.725.9818282.8
≥5%
33.911.165.565.668.8
≥10%
12.55.637.945.954.7
≥15%
≥20%
  • 0.6 mg BI 456906
  • Placebo group
  • 2.4 mg BI456906
  • 3.6 mg BI 456906
  • 4.8 mg BI 456906
Show as table
Arm≥5%≥10%≥15%≥20%
0.6 mg BI 45690660.7%33.9%12.5%n/r
Placebo group25.9%11.1%5.6%n/r
2.4 mg BI45690681%65.5%37.9%n/r
3.6 mg BI 45690682%65.6%45.9%n/r
4.8 mg BI 45690682.8%68.8%54.7%n/r

Not shown

Every selected arm is drawn.